{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "31",
                "@year": "2021",
                "@timestamp": "2021-07-31T05:12:45.000045-04:00",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2018",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {
                "xocs:funding-agency-matched-string": "Chulalongkorn University",
                "xocs:funding-agency-acronym": "CU",
                "xocs:funding-agency": "Chulalongkorn University",
                "xocs:funding-id": "Phar2558-RG03",
                "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
            },
            "xocs:funding-addon-generated-timestamp": "2021-05-27T21:12:29.720Z",
            "xocs:funding-text": [
                {"$": "Acknowledgments We would like to thank all patients who participated in this study, physicians and staffs at research center in Bamrasnaradura Infectious Diseases Institute for their support. This study was funded by The 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund). The authors express our gratitude to the Faculty of Pharmaceutical Sciences, Chulalongkorn University for providing research fund (Grant No. Phar2558-RG03) to Chankit Puttilerpong."},
                {"$": "We would like to thank all patients who participated in this study, physicians and staffs at research center in Bamrasnaradura Infectious Diseases Institute for their support. This study was funded by The 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund). The authors express our gratitude to the Faculty of Pharmaceutical Sciences, Chulalongkorn University for providing research fund (Grant No. Phar2558-RG03) to Chankit Puttilerpong."}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Pharmacy Practice"},
                                {"$": "Faculty of Pharmaceutical Sciences"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113044315"
                            },
                            "@dptid": "113044315"
                        },
                        "author": [
                            {
                                "ce:given-name": "Krisda",
                                "preferred-name": {
                                    "ce:given-name": "Krisda",
                                    "ce:initials": "K.",
                                    "ce:surname": "Boonthos",
                                    "ce:indexed-name": "Boonthos K."
                                },
                                "@seq": "1",
                                "ce:initials": "K.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Boonthos",
                                "@auid": "57202162016",
                                "ce:indexed-name": "Boonthos K."
                            },
                            {
                                "ce:given-name": "Chankit",
                                "preferred-name": {
                                    "ce:given-name": "Chankit",
                                    "ce:initials": "C.",
                                    "ce:surname": "Puttilerpong",
                                    "ce:indexed-name": "Puttilerpong C."
                                },
                                "@seq": "2",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Puttilerpong",
                                "@auid": "56144670800",
                                "ce:indexed-name": "Puttilerpong C."
                            },
                            {
                                "ce:given-name": "Thitima",
                                "preferred-name": {
                                    "ce:given-name": "Thitima",
                                    "ce:initials": "T.",
                                    "ce:surname": "Pengsuparp",
                                    "ce:indexed-name": "Pengsuparp T."
                                },
                                "@seq": "3",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Pengsuparp",
                                "@auid": "6602906247",
                                "ce:indexed-name": "Pengsuparp T."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60015728",
                            "@country": "tha",
                            "city": "Nonthaburi",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Bamrasnaradura Infectious Diseases Institute"},
                                {"$": "Ministry of Public Health"}
                            ],
                            "affiliation-id": {
                                "@afid": "60015728",
                                "@dptid": "103815545"
                            },
                            "@dptid": "103815545"
                        },
                        "author": [{
                            "ce:given-name": "Weerawat",
                            "preferred-name": {
                                "ce:given-name": "Weerawat",
                                "ce:initials": "W.",
                                "ce:surname": "Manosuthi",
                                "ce:indexed-name": "Manosuthi W."
                            },
                            "@seq": "4",
                            "ce:initials": "W.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Manosuthi",
                            "@auid": "57225766218",
                            "ce:indexed-name": "Manosuthi W."
                        }]
                    }
                ],
                "citation-title": "Short-term efficacy and safety of adding Ezetimibe to current regimen of lipid-lowering drugs in human immunodeficiency virus-infected Thai patients treated with protease inhibitors",
                "abstracts": "© 2018, National Institute of Health. All rights reserved.Long-term complications of protease inhibitor (PI) treatment includes increased cardiovascular risks due to dyslipidemia in patients infected with human immunodeficiency virus (HIV). Ezetimibe reduces low-density lipoprotein cholesterol (LDL-C) without drug interactions with PIs and statins. Furthermore, the addition of ezetimibe to statins is an optional treatment in HIV-infected patients with uncontrolled dyslipidemia. The objective of this study was to determine the short-term efficacy and safety of adding ezetimibe to the currently administered statin regimen. Thirty-two patients received ezetimibe (10 mg daily) in addition to their ongoing lipid-lowering therapy for 18 weeks. Serum LDL-C, total cholesterol (TC), triglycerides (TGs), TC/high-density lipoprotein cholesterol (HDL-C) ratio, and HDL-C were measured at baseline, and weeks 6, 12, and 18. Safety parameters were assessed by adverse event reports and laboratory assessments throughout the study. The mean percent change from baseline to endpoint in LDL-C, TC, TGs, and TC/HDL-C ratio were −23.3% (p < 0.001), −15.0% (p = 0.001), −22.1% (p = 0.004), and −16.2% (p = 0.018), respectively. No adverse event or other abnormal laboratory results occurred. Addition of ezetimibe to currently administered lipid-lowering drugs in HIV-infected patients receiving PIs with uncontrolled dyslipidemia demonstrated significantly improved efficacy in reducing their LDL-C, TC, TGs, and TC/HDL-C ratio levels. Moreover, this therapy was safe and well-tolerated.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "postal-code": "10330",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Department of Pharmacy Practice"},
                            {"$": "Faculty of Pharmaceutical Sciences"},
                            {"$": "Chulalongkorn University"}
                        ]
                    },
                    "person": {
                        "ce:given-name": "Chankit",
                        "ce:initials": "C.",
                        "ce:surname": "Puttilerpong",
                        "ce:indexed-name": "Puttilerpong C."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Dyslipidemia",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Ezetimibe",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Human immunodeficiency virus (HIV)",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Protease inhibitor",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Statin",
                            "@xml:lang": "eng"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "https://www.jstage.jst.go.jp/article/yoken/71/3/71_JJID.2017.182/_pdf",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Japanese Journal of Infectious Diseases",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "71",
                            "@issue": "3"
                        },
                        "pagerange": {
                            "@first": "220",
                            "@last": "238"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Japanese Journal of Infectious Diseases",
                    "publicationdate": {
                        "year": "2018",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2018"
                        }
                    },
                    "codencode": "JJIDF",
                    "sourcetitle-abbrev": "Jpn. J. Infect. Dis.",
                    "@country": "jpn",
                    "issn": [
                        {
                            "$": "18842836",
                            "@type": "electronic"
                        },
                        {
                            "$": "13446304",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2018"},
                    "publisher": {
                        "publishername": "National Institute of Health",
                        "ce:e-address": {
                            "$": "jjid@nih.go.jp",
                            "@type": "email"
                        }
                    },
                    "@srcid": "15316"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "29",
                                    "classification-description": "Clinical and Experimental Biochemistry"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "4",
                                    "classification-description": "Microbiology: Bacteriology, Mycology, Parasitology and Virology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2726"},
                                {"$": "2725"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "134523-00-5"},
                                        {"$": "134523-03-8"}
                                    ],
                                    "chemical-name": "atorvastatin"
                                },
                                {
                                    "cas-registry-number": "163222-33-1",
                                    "chemical-name": "ezetimibe"
                                },
                                {
                                    "cas-registry-number": "49562-28-9",
                                    "chemical-name": "fenofibrate"
                                },
                                {
                                    "cas-registry-number": "25812-30-0",
                                    "chemical-name": "gemfibrozil"
                                },
                                {
                                    "cas-registry-number": "37205-61-1",
                                    "chemical-name": "proteinase inhibitor"
                                },
                                {
                                    "cas-registry-number": "57-88-5",
                                    "chemical-name": "cholesterol"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Cholesterol"},
                                {"chemical-name": "Ezetimibe"},
                                {"chemical-name": "HIV Protease Inhibitors"},
                                {"chemical-name": "Hypolipidemic Agents"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "We would like to thank all patients who participated in this study, physicians and staffs at research center in Bamrasnaradura Infectious Diseases Institute for their support. This study was funded by The 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund). The authors express our gratitude to the Faculty of Pharmaceutical Sciences, Chulalongkorn University for providing research fund (Grant No. Phar2558-RG03) to Chankit Puttilerpong.",
                        "@xml:lang": "eng"
                    },
                    "grant": {
                        "grant-id": "Phar2558-RG03",
                        "grant-acronym": "CU",
                        "grant-agency": {
                            "@iso-code": "tha",
                            "$": "Chulalongkorn University"
                        },
                        "grant-agency-id": "501100002873"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2018 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "09",
                    "@year": "2018",
                    "@timestamp": "BST 22:45:08",
                    "@month": "10"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "622276825",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "910812193",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20180366688",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "29709973",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20180904814",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20181649061",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85047305790",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85047305790",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "624200458",
                            "@idtype": "PUIsecondary"
                        }
                    ],
                    "ce:doi": "10.7883/yoken.JJID.2017.182"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "38",
                "reference": [
                    {
                        "ref-fulltext": "Manosuthi W, Ongwandee S, Bhakeecheep S, et al. Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand. AIDS Res Ther. 2015;12:12.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84928230979",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {"@first": "12"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Manosuthi",
                                        "ce:indexed-name": "Manosuthi W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Ongwandee",
                                        "ce:indexed-name": "Ongwandee S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Bhakeecheep",
                                        "ce:indexed-name": "Bhakeecheep S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS Res Ther"
                        }
                    },
                    {
                        "ref-fulltext": "Department of Health and Human Services (DHHS). Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Available at <https://aidsinfo.nih.gov/contentfiles/lvguidelines/Adultand AdolescentGL.pdf >. Accessed April 27, 2017.",
                        "@id": "2",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85041447330",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed April 27, 2017",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Department of Health and Human Services (DHHS)",
                                "ce:indexed-name": "Department of Health and Human Services (DHHS)"
                            }},
                            "ref-sourcetitle": "Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV"
                        }
                    },
                    {
                        "ref-fulltext": "Erb P, Battegay M, Zimmerli W, et al. Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study. Arch Intern Med. 2000;160:1134-40.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0034708984",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "160"},
                                "pagerange": {
                                    "@first": "1134",
                                    "@last": "1140"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Erb",
                                        "ce:indexed-name": "Erb P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Battegay",
                                        "ce:indexed-name": "Battegay M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Zimmerli",
                                        "ce:indexed-name": "Zimmerli W."
                                    }
                                ],
                                "collaboration": {
                                    "@seq": "1",
                                    "ce:text": "Swiss HIV Cohort Study",
                                    "ce:indexed-name": "Swiss HIV Cohort Study"
                                },
                                "et-al": null
                            },
                            "ref-sourcetitle": "Arch Intern Med"
                        }
                    },
                    {
                        "ref-fulltext": "Fellay J, Boubaker K, Ledergerber B, et al. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet. 2001;358:1322-7.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0035922595",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "358"},
                                "pagerange": {
                                    "@first": "1322",
                                    "@last": "1327"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Fellay",
                                        "ce:indexed-name": "Fellay J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Boubaker",
                                        "ce:indexed-name": "Boubaker K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Ledergerber",
                                        "ce:indexed-name": "Ledergerber B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        }
                    },
                    {
                        "ref-fulltext": "Holmberg SD, Moorman AC, Williamson JM, et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet. 2002;360:1747-8.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Protease inhibitors and cardiovascular outcomes in patients with HIV-1"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037202854",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "360"},
                                "pagerange": {
                                    "@first": "1747",
                                    "@last": "1748"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Holmberg",
                                        "ce:indexed-name": "Holmberg S.D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Moorman",
                                        "ce:indexed-name": "Moorman A.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Williamson",
                                        "ce:indexed-name": "Williamson J.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        }
                    },
                    {
                        "ref-fulltext": "Riddler SA, Smit E, Cole SR, et al. Impact of HIV infection and HAART on serum lipids in men. JAMA. 2003;289:2978-82.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Impact of HIV infection and HAART on serum lipids in men"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037805278",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "289"},
                                "pagerange": {
                                    "@first": "2978",
                                    "@last": "2982"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Riddler",
                                        "ce:indexed-name": "Riddler S.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Smit",
                                        "ce:indexed-name": "Smit E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Cole",
                                        "ce:indexed-name": "Cole S.R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA"
                        }
                    },
                    {
                        "ref-fulltext": "Friis-Møller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS. 2003;17:1179-93.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0038386036",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "1179",
                                    "@last": "1193"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Friis-Møller",
                                        "ce:indexed-name": "Friis-Moller N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Weber",
                                        "ce:indexed-name": "Weber R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Reiss",
                                        "ce:indexed-name": "Reiss P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        }
                    },
                    {
                        "ref-fulltext": "Friis-Møller N, Sabin CA, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993-2003.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Combination antiretroviral therapy and the risk of myocardial infarction"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0345064200",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "349"},
                                "pagerange": {
                                    "@first": "1993",
                                    "@last": "2003"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Friis-Møller",
                                        "ce:indexed-name": "Friis-Moller N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Sabin",
                                        "ce:indexed-name": "Sabin C.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Weber",
                                        "ce:indexed-name": "Weber R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        }
                    },
                    {
                        "ref-fulltext": "Grover SA, Coupal L, Gilmore N, et al. Impact of dyslipidemia associated with highly active antiretroviral therapy (HAART) on cardiovascular risk and life expectancy. Am J Cardiol. 2005;95:586-91.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Impact of dyslipidemia associated with highly active antiretroviral therapy (HAART) on cardiovascular risk and life expectancy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "13844255117",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "95"},
                                "pagerange": {
                                    "@first": "586",
                                    "@last": "591"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Grover",
                                        "ce:indexed-name": "Grover S.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Coupal",
                                        "ce:indexed-name": "Coupal L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Gilmore",
                                        "ce:indexed-name": "Gilmore N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Cardiol"
                        }
                    },
                    {
                        "ref-fulltext": "Sackoff JE, Hanna DB, Pfeiffer MR, et al. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145:397-406.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33749175714",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "145"},
                                "pagerange": {
                                    "@first": "397",
                                    "@last": "406"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Sackoff",
                                        "ce:indexed-name": "Sackoff J.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Hanna",
                                        "ce:indexed-name": "Hanna D.B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Pfeiffer",
                                        "ce:indexed-name": "Pfeiffer M.R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Intern Med"
                        }
                    },
                    {
                        "ref-fulltext": "DAD Study Group, Friis-Møller N, Reiss P, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356:1723-35.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Class of antiretroviral drugs and the risk of myocardial infarction"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34247537169",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "356"},
                                "pagerange": {
                                    "@first": "1723",
                                    "@last": "1735"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Friis-Møller",
                                        "ce:indexed-name": "Friis-Moller N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Reiss",
                                        "ce:indexed-name": "Reiss P."
                                    }
                                ],
                                "collaboration": {
                                    "@seq": "1",
                                    "ce:text": "DAD Study Group",
                                    "ce:indexed-name": "DAD Study Group"
                                },
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        }
                    },
                    {
                        "ref-fulltext": "Haubrich RH, Riddler SA, DiRienzo AG, et al. Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. AIDS. 2009;23: 1109-18.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment"},
                            "refd-itemidlist": {"itemid": {
                                "$": "67651096095",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "1109",
                                    "@last": "1118"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Haubrich",
                                        "ce:indexed-name": "Haubrich R.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Riddler",
                                        "ce:indexed-name": "Riddler S.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Dirienzo",
                                        "ce:indexed-name": "Dirienzo A.G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        }
                    },
                    {
                        "ref-fulltext": "Worm SW, Sabin C, Weber R, et al. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (DAD) study. J Infect Dis. 2010; 201:318-30.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: The data collection on adverse events of anti-HIV drugs (DAD) study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "75649093029",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "201"},
                                "pagerange": {
                                    "@first": "318",
                                    "@last": "330"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Worm",
                                        "ce:indexed-name": "Worm S.W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Sabin",
                                        "ce:indexed-name": "Sabin C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Weber",
                                        "ce:indexed-name": "Weber R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Infect Dis"
                        }
                    },
                    {
                        "ref-fulltext": "WHO. Cardiovascular diseases (CVDs), fact sheet N 317. Available at <http://www.who.int/mediacentre/factsheets/fs317/en/>. Accessed April 27, 2017.",
                        "@id": "14",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.who.int/mediacentre/factsheets/fs317/en/",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "77951927068",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed April 27, 2017",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "WHO",
                                "ce:indexed-name": "WHO"
                            }},
                            "ref-sourcetitle": "Cardiovascular Diseases (Cvds), Fact Sheet N 317"
                        }
                    },
                    {
                        "ref-fulltext": "Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486-97.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0035897696",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "285"},
                                "pagerange": {
                                    "@first": "2486",
                                    "@last": "2497"
                                }
                            },
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults",
                                "ce:indexed-name": "Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults"
                            }},
                            "ref-sourcetitle": "JAMA"
                        }
                    },
                    {
                        "ref-fulltext": "Dubé MP, Stein JH, Aberg JA, et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003;37:613-27.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: Recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0042832397",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {
                                    "@first": "613",
                                    "@last": "627"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Dubé",
                                        "ce:indexed-name": "Dube M.P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Stein",
                                        "ce:indexed-name": "Stein J.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Aberg",
                                        "ce:indexed-name": "Aberg J.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        }
                    },
                    {
                        "ref-fulltext": "Grundy SM, Cleeman JI, Merz CNB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-39.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines"},
                            "refd-itemidlist": {"itemid": {
                                "$": "3142729178",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "110"},
                                "pagerange": {
                                    "@first": "227",
                                    "@last": "239"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Grundy",
                                        "ce:indexed-name": "Grundy S.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.I.",
                                        "@_fa": "true",
                                        "ce:surname": "Cleeman",
                                        "ce:indexed-name": "Cleeman J.I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Merz",
                                        "ce:indexed-name": "Merz C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Circulation"
                        }
                    },
                    {
                        "ref-fulltext": "Fichtenbaum CJ, Gerber JG, Rosenkranz SL, et al. Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047. AIDS. 2002;16:569-77.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037040378",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "569",
                                    "@last": "577"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Fichtenbaum",
                                        "ce:indexed-name": "Fichtenbaum C.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Gerber",
                                        "ce:indexed-name": "Gerber J.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Rosenkranz",
                                        "ce:indexed-name": "Rosenkranz S.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        }
                    },
                    {
                        "ref-fulltext": "Hare CB, Vu MP, Grunfeld C, et al. Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death. Clin Infect Dis. 2002; 35:e111-2.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death"},
                            "refd-itemidlist": {"itemid": {
                                "$": "18744364734",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "35"},
                                "pagerange": {
                                    "@first": "e111",
                                    "@last": "e112"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Hare",
                                        "ce:indexed-name": "Hare C.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Vu",
                                        "ce:indexed-name": "Vu M.P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Grunfeld",
                                        "ce:indexed-name": "Grunfeld C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        }
                    },
                    {
                        "ref-fulltext": "Hsyu P-H, Schultz-Smith MD, Lillibridge JH, et al. Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin. Antimicrob Agents Chemother. 2001;45:3445-50.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0035185490",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "3445",
                                    "@last": "3450"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.-H.",
                                        "@_fa": "true",
                                        "ce:surname": "Hsyu",
                                        "ce:indexed-name": "Hsyu P.-H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Schultz-Smith",
                                        "ce:indexed-name": "Schultz-Smith M.D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Lillibridge",
                                        "ce:indexed-name": "Lillibridge J.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        }
                    },
                    {
                        "ref-fulltext": "Chuck SK, Penzak SR. Risk-benefit of HMG-CoA reductase inhibitors in the treatment of HIV protease inhibitor-related hyperlipidemia. Expert Opin Drug Saf. 2002;1:5-17.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Risk-benefit of HMG-CoA reductase inhibitors in the treatment of HIV protease inhibitor-related hyperlipidemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0042737413",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "1"},
                                "pagerange": {
                                    "@first": "5",
                                    "@last": "17"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Chuck",
                                    "ce:indexed-name": "Chuck S.K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Penzak",
                                    "ce:indexed-name": "Penzak S.R."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Opin Drug Saf"
                        }
                    },
                    {
                        "ref-fulltext": "Davis HR, Veltri EP. Zetia: Inhibition of Niemann-Pick C1 like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia. J Atheroscler Thromb. 2007;14:99-108.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Zetia: Inhibition of Niemann-Pick C1 like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34547857877",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "99",
                                    "@last": "108"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Davis",
                                    "ce:indexed-name": "Davis H.R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Veltri",
                                    "ce:indexed-name": "Veltri E.P."
                                }
                            ]},
                            "ref-sourcetitle": "J Atheroscler Thromb"
                        }
                    },
                    {
                        "ref-fulltext": "Sudhop T, Lütjohann D, Kodal A, et al. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation. 2002;106: 1943-8.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Inhibition of intestinal cholesterol absorption by ezetimibe in humans"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037044454",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "106"},
                                "pagerange": {
                                    "@first": "1943",
                                    "@last": "1948"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Sudhop",
                                        "ce:indexed-name": "Sudhop T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Lütjohann",
                                        "ce:indexed-name": "Lutjohann D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Kodal",
                                        "ce:indexed-name": "Kodal A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Circulation"
                        }
                    },
                    {
                        "ref-fulltext": "Knopp RH, Gitter H, Truitt T, et al. Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur Heart J. 2003;24:729-41.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037395141",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "729",
                                    "@last": "741"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Knopp",
                                        "ce:indexed-name": "Knopp R.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Gitter",
                                        "ce:indexed-name": "Gitter H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Truitt",
                                        "ce:indexed-name": "Truitt T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur Heart J"
                        }
                    },
                    {
                        "ref-fulltext": "Jeu L, Cheng JWM. Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor. Clin Ther. 2003;25: 2352-87.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0142043930",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "2352",
                                    "@last": "2387"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Jeu",
                                    "ce:indexed-name": "Jeu L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.W.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Cheng",
                                    "ce:indexed-name": "Cheng J.W.M."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Ther"
                        }
                    },
                    {
                        "ref-fulltext": "Dujovne CA, Ettinger MP, McNeer JF, et al. Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia. Am J Cardiol. 2002;90: 1092-7.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037111924",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "90"},
                                "pagerange": {
                                    "@first": "1092",
                                    "@last": "1097"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Dujovne",
                                        "ce:indexed-name": "Dujovne C.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Ettinger",
                                        "ce:indexed-name": "Ettinger M.P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.F.",
                                        "@_fa": "true",
                                        "ce:surname": "McNeer",
                                        "ce:indexed-name": "McNeer J.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Cardiol"
                        }
                    },
                    {
                        "ref-fulltext": "Kosoglou T, Statkevich P, Johnson-Levonas AO, et al. Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet. 2005;44:467-94.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Ezetimibe: A review of its metabolism, pharmacokinetics and drug interactions"},
                            "refd-itemidlist": {"itemid": {
                                "$": "19544371758",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "44"},
                                "pagerange": {
                                    "@first": "467",
                                    "@last": "494"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Kosoglou",
                                        "ce:indexed-name": "Kosoglou T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Statkevich",
                                        "ce:indexed-name": "Statkevich P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.O.",
                                        "@_fa": "true",
                                        "ce:surname": "Johnson-Levonas",
                                        "ce:indexed-name": "Johnson-Levonas A.O."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacokinet"
                        }
                    },
                    {
                        "ref-fulltext": "Gagné C, Bays HE, Weiss SR, et al. Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. Am J Cardiol. 2002;90:1084-91.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037111890",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "90"},
                                "pagerange": {
                                    "@first": "1084",
                                    "@last": "1091"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Gagné",
                                        "ce:indexed-name": "Gagne C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Bays",
                                        "ce:indexed-name": "Bays H.E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Weiss",
                                        "ce:indexed-name": "Weiss S.R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Cardiol"
                        }
                    },
                    {
                        "ref-fulltext": "Ballantyne CM, Houri J, Notarbartolo A, et al. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: A prospective, randomized, double-blind trial. Circulation.2003;107:2409-15.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: A prospective, randomized, double-blind trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037504445",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "107"},
                                "pagerange": {
                                    "@first": "2409",
                                    "@last": "2415"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Ballantyne",
                                        "ce:indexed-name": "Ballantyne C.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Houri",
                                        "ce:indexed-name": "Houri J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Notarbartolo",
                                        "ce:indexed-name": "Notarbartolo A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Circulation"
                        }
                    },
                    {
                        "ref-fulltext": "Melani L, Mills R, Hassman D, et al. Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: A prospective, randomized, double-blind trial. Eur Heart J. 2003;24:717-28.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: A prospective, randomized, double-blind trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0344490262",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "717",
                                    "@last": "728"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Melani",
                                        "ce:indexed-name": "Melani L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Mills",
                                        "ce:indexed-name": "Mills R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Hassman",
                                        "ce:indexed-name": "Hassman D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur Heart J"
                        }
                    },
                    {
                        "ref-fulltext": "Cannon CP, Blazing MA, Giugliano RP, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015; 372:2387-97.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Ezetimibe added to statin therapy after acute coronary syndromes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84931411520",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "372"},
                                "pagerange": {
                                    "@first": "2387",
                                    "@last": "2397"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Cannon",
                                        "ce:indexed-name": "Cannon C.P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Blazing",
                                        "ce:indexed-name": "Blazing M.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Giugliano",
                                        "ce:indexed-name": "Giugliano R.P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        }
                    },
                    {
                        "ref-fulltext": "Stein E, Stender S, Mata P, et al. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Am Heart J. 2004;148:447-55.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatin"},
                            "refd-itemidlist": {"itemid": {
                                "$": "4644256971",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "148"},
                                "pagerange": {
                                    "@first": "447",
                                    "@last": "455"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Stein",
                                        "ce:indexed-name": "Stein E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Stender",
                                        "ce:indexed-name": "Stender S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Mata",
                                        "ce:indexed-name": "Mata P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am Heart J"
                        }
                    },
                    {
                        "ref-fulltext": "Coll B, Aragonés G, Parra S, et al. Ezetimibe effectively decreases LDL-cholesterol in HIV-infected patients. AIDS. 2006;20:1675-7.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Ezetimibe effectively decreases LDL-cholesterol in HIV-infected patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33746710000",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "1675",
                                    "@last": "1677"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Coll",
                                        "ce:indexed-name": "Coll B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Aragonés",
                                        "ce:indexed-name": "Aragones G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Parra",
                                        "ce:indexed-name": "Parra S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        }
                    },
                    {
                        "ref-fulltext": "Wohl DA, Waters D, Simpson RJ Jr, et al. Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-Infected patients receiving combination antiretroviral therapy. Clin Infect Dis. 2008;47: 1105-8.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-Infected patients receiving combination antiretroviral therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "53349101854",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "47"},
                                "pagerange": {
                                    "@first": "1105",
                                    "@last": "1108"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Wohl",
                                        "ce:indexed-name": "Wohl D.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Waters",
                                        "ce:indexed-name": "Waters D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Simpson",
                                        "ce:suffix": "Jr.",
                                        "ce:indexed-name": "Simpson R.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        }
                    },
                    {
                        "ref-fulltext": "Negredo E, Moltó J, Puig J, et al. Ezetimibe, a promising lipidlowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins. AIDS. 2006;20:2159-64.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Ezetimibe, a promising lipidlowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33750587038",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "2159",
                                    "@last": "2164"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Negredo",
                                        "ce:indexed-name": "Negredo E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Moltó",
                                        "ce:indexed-name": "Molto J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Puig",
                                        "ce:indexed-name": "Puig J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        }
                    },
                    {
                        "ref-fulltext": "van den Berg-Wolf M, Klibanov OM, Gaughan JP, et al. Ezetimibe combined with low-dose statin effectively lowers LDL in protease inhibitor treated patients. AIDS Patient Care STDS. 2008;22:483-8.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Ezetimibe combined with low-dose statin effectively lowers LDL in protease inhibitor treated patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "47949085089",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "483",
                                    "@last": "488"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Den Berg-Wolf",
                                        "ce:indexed-name": "Van Den Berg-Wolf M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Klibanov",
                                        "ce:indexed-name": "Klibanov O.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Gaughan",
                                        "ce:indexed-name": "Gaughan J.P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS Patient Care STDS"
                        }
                    },
                    {
                        "ref-fulltext": "Chow D, Chen H, Glesby MJ, et al. Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients. AIDS. 2009;23: 2133-41.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77956504237",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "2133",
                                    "@last": "2141"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Chow",
                                        "ce:indexed-name": "Chow D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Glesby",
                                        "ce:indexed-name": "Glesby M.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        }
                    },
                    {
                        "ref-fulltext": "Hiransuthikul N, Hiransuthikul P, Kanasook Y. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors. Southeast Asian J Trop Med Public Health. 2007;38:69-77.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33947581631",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "38"},
                                "pagerange": {
                                    "@first": "69",
                                    "@last": "77"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Hiransuthikul",
                                    "ce:indexed-name": "Hiransuthikul N."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Hiransuthikul",
                                    "ce:indexed-name": "Hiransuthikul P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Kanasook",
                                    "ce:indexed-name": "Kanasook Y."
                                }
                            ]},
                            "ref-sourcetitle": "Southeast Asian J Trop Med Public Health"
                        }
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "60015728",
            "affilname": "Thailand Ministry of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85047305790",
        "dc:description": "Long-term complications of protease inhibitor (PI) treatment includes increased cardiovascular risks due to dyslipidemia in patients infected with human immunodeficiency virus (HIV). Ezetimibe reduces low-density lipoprotein cholesterol (LDL-C) without drug interactions with PIs and statins. Furthermore, the addition of ezetimibe to statins is an optional treatment in HIV-infected patients with uncontrolled dyslipidemia. The objective of this study was to determine the short-term efficacy and safety of adding ezetimibe to the currently administered statin regimen. Thirty-two patients received ezetimibe (10 mg daily) in addition to their ongoing lipid-lowering therapy for 18 weeks. Serum LDL-C, total cholesterol (TC), triglycerides (TGs), TC/high-density lipoprotein cholesterol (HDL-C) ratio, and HDL-C were measured at baseline, and weeks 6, 12, and 18. Safety parameters were assessed by adverse event reports and laboratory assessments throughout the study. The mean percent change from baseline to endpoint in LDL-C, TC, TGs, and TC/HDL-C ratio were −23.3% (p < 0.001), −15.0% (p = 0.001), −22.1% (p = 0.004), and −16.2% (p = 0.018), respectively. No adverse event or other abnormal laboratory results occurred. Addition of ezetimibe to currently administered lipid-lowering drugs in HIV-infected patients receiving PIs with uncontrolled dyslipidemia demonstrated significantly improved efficacy in reducing their LDL-C, TC, TGs, and TC/HDL-C ratio levels. Moreover, this therapy was safe and well-tolerated.",
        "pubmed-id": "29709973",
        "prism:coverDate": "2018-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85047305790",
        "dc:creator": {"author": [{
            "ce:given-name": "Krisda",
            "preferred-name": {
                "ce:given-name": "Krisda",
                "ce:initials": "K.",
                "ce:surname": "Boonthos",
                "ce:indexed-name": "Boonthos K."
            },
            "@seq": "1",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Boonthos",
            "@auid": "57202162016",
            "author-url": "https://api.elsevier.com/content/author/author_id/57202162016",
            "ce:indexed-name": "Boonthos K."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85047305790"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85047305790&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85047305790&origin=inward"
            }
        ],
        "source-id": "15316",
        "citedby-count": "2",
        "prism:volume": "71",
        "subtype": "ar",
        "dc:title": "Short-term efficacy and safety of adding Ezetimibe to current regimen of lipid-lowering drugs in human immunodeficiency virus-infected Thai patients treated with protease inhibitors",
        "openaccess": "1",
        "prism:issn": "18842836 13446304",
        "publishercopyright": "© 2018, National Institute of Health. All rights reserved.",
        "prism:issueIdentifier": "3",
        "subtypeDescription": "Article",
        "prism:publicationName": "Japanese Journal of Infectious Diseases",
        "prism:pageRange": "220-238",
        "prism:endingPage": "238",
        "openaccessFlag": "true",
        "prism:doi": "10.7883/yoken.JJID.2017.182",
        "prism:startingPage": "220",
        "dc:identifier": "SCOPUS_ID:85047305790",
        "dc:publisher": "National Institute of Healthjjid@nih.go.jp"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antiretroviral Therapy, Highly Active",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Cholesterol",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Ezetimibe",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "HIV Infections",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "HIV Protease Inhibitors",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hypolipidemic Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Prospective Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Thailand",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Dyslipidemia"
        },
        {
            "@_fa": "true",
            "$": "Ezetimibe"
        },
        {
            "@_fa": "true",
            "$": "Human immunodeficiency virus (HIV)"
        },
        {
            "@_fa": "true",
            "$": "Protease inhibitor"
        },
        {
            "@_fa": "true",
            "$": "Statin"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Krisda",
            "preferred-name": {
                "ce:given-name": "Krisda",
                "ce:initials": "K.",
                "ce:surname": "Boonthos",
                "ce:indexed-name": "Boonthos K."
            },
            "@seq": "1",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Boonthos",
            "@auid": "57202162016",
            "author-url": "https://api.elsevier.com/content/author/author_id/57202162016",
            "ce:indexed-name": "Boonthos K."
        },
        {
            "ce:given-name": "Chankit",
            "preferred-name": {
                "ce:given-name": "Chankit",
                "ce:initials": "C.",
                "ce:surname": "Puttilerpong",
                "ce:indexed-name": "Puttilerpong C."
            },
            "@seq": "2",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Puttilerpong",
            "@auid": "56144670800",
            "author-url": "https://api.elsevier.com/content/author/author_id/56144670800",
            "ce:indexed-name": "Puttilerpong C."
        },
        {
            "ce:given-name": "Thitima",
            "preferred-name": {
                "ce:given-name": "Thitima",
                "ce:initials": "T.",
                "ce:surname": "Pengsuparp",
                "ce:indexed-name": "Pengsuparp T."
            },
            "@seq": "3",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Pengsuparp",
            "@auid": "6602906247",
            "author-url": "https://api.elsevier.com/content/author/author_id/6602906247",
            "ce:indexed-name": "Pengsuparp T."
        },
        {
            "ce:given-name": "Weerawat",
            "preferred-name": {
                "ce:given-name": "Weerawat",
                "ce:initials": "W.",
                "ce:surname": "Manosuthi",
                "ce:indexed-name": "Manosuthi W."
            },
            "@seq": "4",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60015728",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728"
            },
            "ce:surname": "Manosuthi",
            "@auid": "57225766218",
            "author-url": "https://api.elsevier.com/content/author/author_id/57225766218",
            "ce:indexed-name": "Manosuthi W."
        }
    ]}
}}